Cresset Biomolecular Discovery
Industry | Drug Discovery, Chemistry Software |
---|---|
Founded | 2002 |
Founder(s) | Dr. Andy Vinter |
Headquarters | Cambridgeshire, United Kingdom |
Key people | Rob Scoffin, CEO, |
Website | www.cresset-group.com |
Cresset is a chemistry software company formed in 2002, specializing in virtual screening technology used in computational chemistry and medicinal chemistry. The company is based in the UK and sells mainly to pharmaceutical, biotechnology and academic research groups. Cresset software is based upon field point technology,[1] which uses molecular field extrema as a means of finding biologically relevant regions of molecules.
Cresset's products have traditionally solveed key problems faced by computational chemists, such as ligand based virtual screening (Blaze), bioisostere identification (Spark), bioactive conformation determination (Forge) and ligand alignment (Torch). However, our field technology has been adopted in a wide range of markets involved in all aspects of molecule discovery and design.
Cresset has partnerships with pharmaceutical, contract research, software, and information organisations including Syrris, PerkinElmer Informatics, Peakdale Molecular and Optibrium.
Products
- Torch, intuitive 3D molecule designer
- TorchLite, free 3D molecule viewing, editing and drawing
- Spark, discover new directions for your project using bioisosteres
- Forge, powerful computational suite to understand SAR and design
- Blaze, effective ligand based virtual screening
- BlazeGPU, superfast new lead generation
- XedTools, access to one of the most innovative molecular mechanics force fields currently in existence
- Project Services
- Software as a Service
- CompChem on Demand
References
External links
- Cresset official homepage
- Cresset Software Helps Create New Ideas to Suggest New Chemistry or to Overcome Existing Patents
- Using Cresset's Fields to Find CDC25 Inhibitors
- The Cresset Advantage
- Scientific Consulting
- Academic Access